EverSource Wealth Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1710537
BIRMINGHAM, AL
Position in REGN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,452,556
+$400,503 QoQ
Shares Held
1,880
+37.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EverSource Wealth Advisors, LLC holds $14,924,651 across 265 Biotechnology names. REGN ranks #2 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
89,683 | $4,266,217 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,880 | $1,452,556 | |
| 3 | INCY |
Incyte Corp
|
13,070 | $1,230,145 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,507 | $672,929 | |
| 5 | RPRX |
Royalty Pharma plc
|
12,629 | $605,808 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
26,026 | $544,460 | |
| 7 | EXEL |
Exelixis, Inc.
|
11,015 | $472,428 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
6,845 | $386,665 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,452,556 | 1,880 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,052,053 | 1,363 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $583,071 | 1,037 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $221,025 | 421 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $344,384 | 543 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $334,792 | 470 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $662,278 | 630 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $667,403 | 635 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $496,641 | 516 | Shares | Sole | 2024-06-11 | |
| 2023-12-31 | $461,098 | 525 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $464,146 | 564 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $345,616 | 481 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $344,277 | 419 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $305,189 | 423 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $183,927 | 267 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $170,835 | 289 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $116,635 | 167 | Shares | Sole | 2022-05-25 | |
| 2021-12-31 | $95,990 | 152 | Shares | Sole | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||